The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Regeneron Pharmaceuticals, Inc(NASDAQ:REGN) 
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovas...
Website: http://www.regeneron.com
Founded: 1988
Full Time Employees: 8,314
Sector: Healthcare
Industry: Biotechnology
Regeneron Pharmaceuticals Number of Twitter Followers
Regeneron Pharmaceuticals Days Payable Outstanding ttm (DPO)
Regeneron Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Regeneron Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Regeneron Pharmaceuticals Op Cashflow Per Share ttm
Regeneron Pharmaceuticals Free Cashflow Per Share ttm
Regeneron Pharmaceuticals Cash Per Share ttm
Regeneron Pharmaceuticals P/S ratio ttm
Regeneron Pharmaceuticals (GAAP) P/E ratio ttm
Regeneron Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.